Chronic inflammation and cancer: suppressing the suppressors.
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisPhenotypic T cell exhaustion in a murine model of bacterial infection in the setting of pre-existing malignancyA multi-targeted approach to suppress tumor-promoting inflammationUpregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cellsAntiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerMyeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils.Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.Prospective study of dietary inflammatory index and risk of breast cancer in Swedish womenTRAF3: a novel tumor suppressor gene in macrophages.Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity.Interleukin-6 Induced "Acute" Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics.Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells.Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis.Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies.The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.Host manipulation by cancer cells: Expectations, facts, and therapeutic implications.Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy.Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells.The Dietary Inflammatory Index Is Associated with Colorectal Cancer Risk in the Multiethnic Cohort.Association between inflammatory potential of diet and mortality among women in the Swedish Mammography Cohort.Perspective on the dynamics of cancer.Adaptive Resistance to Cancer Immunotherapy.Editorial: Two MDSC faces in obesity: Correcting metabolic dysfunctions but promoting tumor development.Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis.Dietary inflammatory index and risk of upper aerodigestive tract cancer in Japanese adults.Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.Age- and sex-related differences in body composition in healthy subjects aged 18 to 82 years.High Expression of NLRC5 is associated with prognosis of gastric cancerP2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer
P2860
Q26786160-78E73054-3466-4C07-AD00-A381C56595C9Q27346770-5E771A95-83B3-40DA-A52F-387BCED05BFFQ28393278-89453746-604C-4605-9292-A0213261C4CEQ28596960-7F10F934-A80C-49CF-A2FE-C7BC1D1302A2Q33779691-6B9A4783-8599-439B-A38C-EC3592882A8EQ34749424-EC03B759-DA3C-42DC-93B0-E207453082FDQ34899627-EB13C722-A12E-47DE-B543-F5D825F1D095Q35090032-94A87B37-B6BC-4A71-9C7F-A76CE52019FAQ35169807-2C160D12-5A8A-4788-9A19-83AC44233D17Q35594253-E4274DF0-DB60-4278-9894-590BF0378EBEQ36295050-8B6E8450-93FF-4E47-8799-046B57BB030EQ36357661-67D3D8E3-343C-4D1A-B236-F386DDB93ACEQ36710977-FE565357-D9FF-4F89-9E2E-FAAC67BE27C4Q36882938-8E3B6C80-BB68-49DF-8095-FC7848FA85FCQ37665260-70C5E4FC-3966-4568-9766-C8AEA427A9FFQ37747652-5433CD95-8761-48A8-B8E2-AD30BB40C9AEQ38393888-B2A0AE71-74CE-411E-A378-4DD48A121EA8Q38584232-7B112B4E-1E97-43F8-A2CF-2FC0DAC677FDQ38724178-608B564B-8A59-47DC-89D8-A9B7FA76533DQ38844417-19B7BFB7-F086-464A-AF37-8C578E8BD5DDQ39093312-595DF06C-999D-4B10-BA30-A4B045A9FBCEQ40343659-38BAC71E-DE2B-47AA-B3EE-9B71BCC755F8Q41529473-FB59FEC8-E0DB-4956-ABA2-0B2450FB7807Q42284422-05157A2A-5112-4BE2-B449-D650BB0073B8Q47252744-F9309C5D-13F4-47AA-B3E4-D422276FE791Q49973179-C0923EC9-89CB-4334-8C47-1F2D86D79A81Q55029432-F61B080C-88A8-4A96-9B36-2D313EF34CAAQ55230646-D6A3ABDB-A508-4D8B-A890-88A5DBCF42EAQ55279094-48D04F29-697D-4743-B3C4-C8C3303626DAQ55514760-0F6D5951-14DA-4FCA-B031-A6FCCCF0521BQ58695802-E23159C0-2BFD-4719-90B1-7E55F79C743EQ58764032-93987D98-7E03-4E8E-886E-43288EEF129F
P2860
Chronic inflammation and cancer: suppressing the suppressors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chronic inflammation and cancer: suppressing the suppressors.
@en
type
label
Chronic inflammation and cancer: suppressing the suppressors.
@en
prefLabel
Chronic inflammation and cancer: suppressing the suppressors.
@en
P2093
P2860
P1476
Chronic inflammation and cancer: suppressing the suppressors.
@en
P2093
Julia Kanterman
Michal Baniyash
Moshe Sade-Feldman
P2860
P2888
P356
10.1007/S00262-013-1468-9
P577
2013-08-29T00:00:00Z
P5875
P6179
1005198827